ArticleThe Journal of adolescent health : official publication of the Society for Adolescent Medicine2025
Hypothalamic-Pituitary-Adrenal Axis Recalibration During Puberty Among Maltreated Youth: The Role of Caregiver Depression.
Article in The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Rifaximin improves anxiety- and depression-like behaviors in rats by regulating NPY in the colon and mPFC.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purposeTo examine trajectories of hypothalamic-pituitary-adrenal (HPA) axis sensitivity, we tested growth models of cortisol reactivity before and during puberty using longitudinal data from maltreated and comparison adolescents. Moderating effects of parental depressive symptoms on pubertal cortisol reactivity slope tested for HPA axis recalibration.
methodsYouth (N = 454) completed 4 assessments across 10 years (Wave 1 M
resultsCortisol reactivity did not change before Tanner 3 but increased in the years following Tanner 3 in both girls and boys. The interaction was significant between parental depressive symptoms at Tanner 3 and post-Tanner 3 cortisol reactivity trajectory among those with PA/SA exposure prepuberty. DISCUSSION: The results indicate possible recalibration of the HPA axis where youth with childhood PA/SA exposure and benevolent family environments (i.e., no parental depressive symptoms, stable caregiver) appeared to regain the expected developmental pattern of increasing cortisol reactivity during puberty. This indicates puberty as a key developmental period to regulate HPA functioning and mitigate potential associated physical and mental health outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.